Maureen T. DeCenzo

875 total citations
13 papers, 773 citations indexed

About

Maureen T. DeCenzo is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Maureen T. DeCenzo has authored 13 papers receiving a total of 773 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 6 papers in Oncology and 6 papers in Immunology. Recurrent topics in Maureen T. DeCenzo's work include Signaling Pathways in Disease (9 papers), Toxin Mechanisms and Immunotoxins (6 papers) and Peptidase Inhibition and Analysis (5 papers). Maureen T. DeCenzo is often cited by papers focused on Signaling Pathways in Disease (9 papers), Toxin Mechanisms and Immunotoxins (6 papers) and Peptidase Inhibition and Analysis (5 papers). Maureen T. DeCenzo collaborates with scholars based in United States. Maureen T. DeCenzo's co-authors include David J. Livingston, Olga Futer, Robert A. Aldape, Mark A. Murcko, Matthew W. Harding, Matt Benasutti, Judith A. Lippke, Mark Fleming, Debra A. Peattie and So‐Hyun Park and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Immunology.

In The Last Decade

Maureen T. DeCenzo

13 papers receiving 753 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maureen T. DeCenzo United States 12 683 246 233 47 43 13 773
David A. Yost United States 11 469 0.7× 175 0.7× 200 0.9× 16 0.3× 17 0.4× 19 790
Jan Schultz Switzerland 15 290 0.4× 223 0.9× 146 0.6× 54 1.1× 27 0.6× 19 677
Michael Stöhr Germany 13 443 0.6× 107 0.4× 102 0.4× 21 0.4× 21 0.5× 21 641
Jeffrey A Radding United States 16 481 0.7× 110 0.4× 86 0.4× 53 1.1× 74 1.7× 25 855
Preeti Joshi United States 9 609 0.9× 63 0.3× 57 0.2× 90 1.9× 36 0.8× 10 771
Abbas Rashidbaigi United States 15 326 0.5× 337 1.4× 197 0.8× 17 0.4× 11 0.3× 35 753
Ashley Hutchinson Canada 12 347 0.5× 88 0.4× 48 0.2× 41 0.9× 22 0.5× 23 670
Peter Savory United Kingdom 12 620 0.9× 84 0.3× 136 0.6× 18 0.4× 16 0.4× 14 746
Tobias Aumüller Germany 12 642 0.9× 146 0.6× 180 0.8× 9 0.2× 67 1.6× 16 744
James J. Greene United States 15 378 0.6× 122 0.5× 51 0.2× 65 1.4× 8 0.2× 32 691

Countries citing papers authored by Maureen T. DeCenzo

Since Specialization
Citations

This map shows the geographic impact of Maureen T. DeCenzo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maureen T. DeCenzo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maureen T. DeCenzo more than expected).

Fields of papers citing papers by Maureen T. DeCenzo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maureen T. DeCenzo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maureen T. DeCenzo. The network helps show where Maureen T. DeCenzo may publish in the future.

Co-authorship network of co-authors of Maureen T. DeCenzo

This figure shows the co-authorship network connecting the top 25 collaborators of Maureen T. DeCenzo. A scholar is included among the top collaborators of Maureen T. DeCenzo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maureen T. DeCenzo. Maureen T. DeCenzo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Joseph‐McCarthy, Diane, Kevin Parris, Adrian Huang, et al.. (2005). Use of Structure-Based Drug Design Approaches to Obtain Novel Anthranilic Acid Acyl Carrier Protein Synthase Inhibitors. Journal of Medicinal Chemistry. 48(25). 7960–7969. 27 indexed citations
2.
DeCenzo, Maureen T., Mike Kuranda, John Babiak, et al.. (2002). Identification of Compounds That Inhibit Late Steps of Peptidoglycan Synthesis in Bacteria.. The Journal of Antibiotics. 55(3). 288–295. 21 indexed citations
3.
Futer, Olga, Michael D. Sintchak, Paul R. Caron, et al.. (2002). A mutational analysis of the active site of human type II inosine 5′-monophosphate dehydrogenase. Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology. 1594(1). 27–39. 20 indexed citations
4.
Mani, Nagraj, et al.. (1998). Screening Systems for Detecting Inhibitors of Cell Wall Transglycosylation in Enterococcus.Cell Wall Transglycosylation Inhibitors in Enterococcus.. The Journal of Antibiotics. 51(5). 471–479. 30 indexed citations
5.
DeCenzo, Maureen T., et al.. (1996). FK506-binding protein mutational analysis: defining the active-site residue contributions to catalysis and the stability of ligand complexes. Protein Engineering Design and Selection. 9(2). 173–180. 70 indexed citations
6.
Itoh, Susumu, Maureen T. DeCenzo, David J. Livingston, David A. Pearlman, & Manuel A. Navia. (1995). Conformation of FK506 in X-ray structures of its complexes with human recombinant FKBP12 mutants. Bioorganic & Medicinal Chemistry Letters. 5(17). 1983–1988. 25 indexed citations
7.
Armistead, David M., Michael C. Badia, David D. Deininger, et al.. (1995). Design, synthesis and structure of non-macrocyclic inhibitors of FKBP12, the major binding protein for the immunosuppressant FK506. Acta Crystallographica Section D Biological Crystallography. 51(4). 522–528. 52 indexed citations
8.
Futer, Olga, Maureen T. DeCenzo, Robert A. Aldape, & David J. Livingston. (1995). FK506 Binding Protein Mutational Analysis. Journal of Biological Chemistry. 270(32). 18935–18940. 51 indexed citations
9.
Lepre, Christopher A., et al.. (1994). Solution Structure of FK506 Bound to the R42K, H87V Double Mutant of FKBP-12. Biochemistry. 33(46). 13571–13580. 10 indexed citations
10.
Nelson, P., Akinori Kawamura, Michael Su, et al.. (1993). Immunosuppressive activity of [MeBm2t]1-, D-diaminobutyryl-8-, and D-diaminopropyl-8-cyclosporin analogues correlates with inhibition of calcineurin phosphatase activity. The Journal of Immunology. 150(6). 2139–2147. 36 indexed citations
11.
Peattie, Debra A., Matthew W. Harding, Mark Fleming, et al.. (1992). Expression and characterization of human FKBP52, an immunophilin that associates with the 90-kDa heat shock protein and is a component of steroid receptor complexes.. Proceedings of the National Academy of Sciences. 89(22). 10974–10978. 226 indexed citations
12.
Park, So‐Hyun, Robert A. Aldape, Olga Futer, Maureen T. DeCenzo, & David J. Livingston. (1992). PPIase catalysis by human FK506-binding protein proceeds through a conformational twist mechanism.. Journal of Biological Chemistry. 267(5). 3316–3324. 89 indexed citations
13.
Aldape, Robert A., et al.. (1992). Charged surface residues of FKBP12 participate in formation of the FKBP12-FK506-calcineurin complex.. Journal of Biological Chemistry. 267(23). 16029–16032. 116 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026